Ruditapes philippinarum Polysaccharide Alleviates Hyperglycemia by Modulating Gut Microbiota in a Mouse Model of Type 2 Diabetes Mellitus

被引:0
作者
Chen, Zhuo [1 ]
Ge, Xiaodong [1 ]
Wang, Yaolin [1 ]
Zhang, Jiawei [1 ]
Sui, Yinzi [1 ]
Yin, Xuemei [1 ]
Wu, Na [1 ]
Yang, Lei [1 ]
Xu, Jianda [2 ]
Zhou, Hongcheng [3 ]
Wu, Qin [3 ]
Zeng, Feng [4 ]
Liu, Liang [1 ]
Shao, Rong [1 ]
Xu, Wei [1 ]
机构
[1] Yancheng Inst Technol, Coll Marine & Bioengn, Yancheng, Peoples R China
[2] Nanjing Univ Chinese Med, Changzhou Hosp, Dept Orthopaed, Changzhou, Peoples R China
[3] Jiangsu Med Coll, Sch Med, Yancheng, Peoples R China
[4] Fujian Agr & Forestry Univ, Coll Food Sci, Fuzhou, Fujian, Peoples R China
关键词
hypoglycemic; gut microbiota; polysaccharides; Ruditapes philippinarum; type 2 diabetes mellitus; BETA-CELL FUNCTION; GLUCOSE; HOMEOSTASIS; EXTRACT; OBESITY; HEALTH; STRAIN; ACIDS; MICE;
D O I
10.1002/mnfr.202400996
中图分类号
TS2 [食品工业];
学科分类号
0832 ;
摘要
Type 2 diabetes mellitus (T2DM), a widespread chronic metabolic disorder, presents a global challenge. Metformin hydrochloride, although widely prescribed, is associated with notable side effects. This study aims to explore safer, more effective alternatives by assessing the impact of Ruditapes philippinarum polysaccharides (RPPs) on glycemic control and modulation of microbiota in T2DM mice. A T2DM mouse model was established through a high-sucrose/high-fat diet and intraperitioneal streptozotocin injection. Glycometabolism indicators, histopathological features, and gut microbiota composition in caecum samples were assessed. Following 4 weeks of RPPs intervention, fasting blood glucose (FBG), glycated serum protein (GSP), area under the curve (AUC) of oral glucose tolerance test (OGTT), total cholesterol (TC), triglyceride (TG), and low-density lipoprotein cholesterol (LDL-c) levels were reduced in T2DM mice, while AKT-1 and GLUT-2 transcription levels were significant increased. Short-chain fatty acids (SCFAs) concentrations notably increased in the RPP-L group compared to the Model group, with improvements also observed in medium-chain fatty acids (MCFAs) and secondary bile acids (SBAs). Regarding gut microbiota, the Firmicutes-to-Bacteroidetes (F/B) ratio in RPP-L was substantially lower than in the Model group. At the genus level, beneficial bacteria, such as Akkermansia, Alloprevotella, Tidjanibacter, and Faecalibaculum demonstrated increased abundance. Correlation analysis identified Muribaculum, Paramuribaculum, Lacrimispora, and Turicibacter as microbial taxa associated with T2DM progression. RPPs significantly alleviated hyperglycemic symptoms in T2DM mice while enhancing the presence of beneficial gut bacteria, leading to a marked improvement in intestinal microbiota composition. This research offers foundational insights for the potential use of R. philippinarum in biomedical and nutraceutical applications.
引用
收藏
页数:14
相关论文
共 50 条
  • [31] The role of gut microbiota in the development of type 1, type 2 diabetes mellitus and obesity
    Tai, Ningwen
    Wong, F. Susan
    Wen, Li
    REVIEWS IN ENDOCRINE & METABOLIC DISORDERS, 2015, 16 (01) : 55 - 65
  • [32] Considering gut microbiota in treatment of type 2 diabetes mellitus
    Adeshirlarijaney, Aneseh
    Gewirtz, Andrew T.
    GUT MICROBES, 2020, 11 (03) : 253 - 264
  • [33] Gut microbiota and immunopathogenesis of diabetes mellitus type 1 and 2
    Wang, Fei
    Zhang, Chunfang
    Zeng, Qiang
    FRONTIERS IN BIOSCIENCE-LANDMARK, 2016, 21 : 900 - 906
  • [34] Characteristics of the Gut Microbiota and Potential Effects of Probiotic Supplements in Individuals with Type 2 Diabetes mellitus
    Ballan, Rafael
    Saad, Susana Marta Isay
    FOODS, 2021, 10 (11)
  • [35] A novel model mouse for type 2 diabetes mellitus with early onset and persistent hyperglycemia
    Ohno, Tamio
    Miyasaka, Yuki
    Yoshida, Kanta
    Kobayashi, Misato
    Horio, Fumihiko
    Yokoi, Norihide
    Mizuno, Masashi
    Ikegami, Hiroshi
    EXPERIMENTAL ANIMALS, 2022, 71 (04) : 510 - 518
  • [36] Gut microbiota modulating therapy for diabetes mellitus should be individualized
    Wang, Jin
    Wei, Hong-Juan
    Mao, Rui-Feng
    Chang, Xin
    WORLD JOURNAL OF DIABETES, 2024, 15 (10)
  • [37] The Association of Targeted Gut Microbiota with Body Composition in Type 2 Diabetes Mellitus
    Hung, Wei-Chun
    Hung, Wei-Wen
    Tsai, Hui-Ju
    Chang, Chen-Chia
    Chiu, Yi-Wen
    Hwang, Shang-Jyh
    Kuo, Mei-Chuan
    Chen, Szu-Chia
    Dai, Chia-Yen
    Tsai, Yi-Chun
    INTERNATIONAL JOURNAL OF MEDICAL SCIENCES, 2021, 18 (02): : 511 - 519
  • [38] Role of gut microbiota in the pathogenesis of type 2 diabetes mellitus (literature review)
    Koval, S. M.
    Snihurska, I. O.
    MEDICNI PERSPEKTIVI, 2021, 26 (04): : 22 - 30
  • [39] Gut Microbiota and Subclinical Cardiovascular Disease in Patients with Type 2 Diabetes Mellitus
    Tsai, Hui-Ju
    Tsai, Wei-Chung
    Hung, Wei-Chun
    Hung, Wei-Wen
    Chang, Chen-Chia
    Dai, Chia-Yen
    Tsai, Yi-Chun
    NUTRIENTS, 2021, 13 (08)
  • [40] Synbiotics and Gut Microbiota: New Perspectives in the Treatment of Type 2 Diabetes Mellitus
    Jiang, Haoran
    Cai, Miaomiao
    Shen, Boyuan
    Wang, Qiong
    Zhang, Tongcun
    Zhou, Xiang
    FOODS, 2022, 11 (16)